M. Barclay

First name
M.
Last name
Barclay
Harrison, H., Ip, S., Renzi, C., Li, Y., Barclay, M., Usher-Smith, J., et al. (2024). Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort. Bmc Med Res Methodol, 24, 71. http://doi.org/10.1186/s12874-024-02175-9
Barclay, M., Renzi, C., Antoniou, A., Denaxas, S., Harrison, H., Ip, S., et al. (2023). Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold. Plos Digit Health, 2, e0000383. http://doi.org/10.1371/journal.pdig.0000383
Wickramasinghe, B., Renzi, C., Barclay, M., Callister, M. E. J., Rafiq, M., & Lyratzopoulos, G. (2023). Pre-diagnostic prescribing patterns in dyspnoea patients with as-yet-undiagnosed lung cancer: A longitudinal study of linked primary care and cancer registry data. Cancer Epidemiol, 86, 102429. http://doi.org/10.1016/j.canep.2023.102429
White, B., Renzi, C., Barclay, M., & Lyratzopoulos, G. (2023). Underlying cancer risk among patients with fatigue and other vague symptoms: a population-based cohort study in primary care. Br J Gen Pract, 73, e75-e87. http://doi.org/10.3399/bjgp.2022.0371